Join the Oncology Voice Network. Join for Free
Making Cancer Care Advances Reach Everyone
onoclogist research sharing

Making Cancer Care Advances Reach Everyone


Share This Article



Can breakthrough discoveries in oncology truly help patients if the latest knowledge never reaches the frontlines? In this episode of the Oncology Voice Network, Dr. Kirk Shepard sits down with Simon Choudhury, a pioneering GU oncologist and Chief Medical Officer at Open Medicine, to expose one of cancer care’s most overlooked challenges: bridging the knowledge divide between academic centers and local hospitals. Simon Choudhury draws from personal experience, including his own mother’s cancer journey, to reveal why practice-changing research often fails to reach the broader communities where most patients are treated. Hear how Open Medicine is reimagining oncology education with AI-powered, user-friendly platforms that give doctors access to up-to-the-minute, hands-on guidance for even the toughest cases. This episode unpacks concrete solutions and urgent calls for more open, rapid, and actionable knowledge-sharing in cancer. Listen now and help close the gap in cancer care. Learn more about Open Medicine’s new algorithm for Daraxonrasib here.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Explore OVN